A Study of SGN-B6A in Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Carcinoma, Non-Small Cell Lung|Squamous Cell Carcinoma of Head and Neck|HER2 Negative Breast Neoplasms|Esophageal Squamous Cell Carcinoma|Esophageal Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Ovarian Neoplasms|Cutaneous Squamous Cell Cancer|Exocrine Pancreatic Adenocarcinoma|Urinary Bladder Neoplasms|Uterine Cervical Neoplasms|Stomach Neoplasms
Interventions: DRUG: sigvotatug vedotin|DRUG: pembrolizumab|DRUG: cisplatin|DRUG: carboplatin
Sponsor: Seagen Inc.